“…The compound has been shown to affect many neural substrates, including its targeting of the kappa-opioid receptor (KOR) system, an opioid receptor subtype implicated in decision-making and impulsivity, 6 and central release of its endogenous ligand, dynorphin. [3][4][5] Li et al 7 have also shown for the first time that the apelin receptor (APJ) and KOR, two members of the family A of Gprotein-coupled receptors, form a heterodimer that increases PKC activity. Moreover, the pro-depressant characteristics of central administration of apelin-13 may be mediated at least in part by KOR in mice.…”